Background: The risk of type 2 diabetes is increasing in teenage girls, and is associated with their greater insulin resistance (IR).
adults, where men are reported to be at higher risk than women. 7, 8 The explanation for the gender difference in the prevalence of T2D between adults and adolescents is uncertain, however, it has been proposed that endocrine changes leading to pubertal insulin resistance (IR) may be among the factors influencing the risk of T2D in children. 9 There may be a "cross-over" of the gender difference in IR between childhood and adulthood, with a decline in IR in postpubertal females relative to males. These changes could reflect age-and gender-dependent changes in adiposity. Logue et al 10 reported that men develop T2D at a lower body mass index (BMI) than women, and suggested this was because men are more insulin resistant and have more central fat than women.
Cross-sectional studies at birth 11 and throughout the prepubertal years 12, 13 have consistently shown higher fasting insulin concentrations in females. These have also been observed in longitudinal studies during adolescence. 14, 15 The EarlyBird longitudinal study has previously reported higher levels of IR in 5-year-old girls compared with boys, even after accounting for differences in adiposity and physical activity. 16 Moreover, it is well established that puberty is associated with a substantial increase in IR. 17, 18 Gender differences in IR have been attributed to differences in adiposity, fat distribution, sex hormones, and pubertal timing. 19, 20 The temporal influence of different factors can only be investigated with longitudinal studies. EarlyBird is a unique longitudinal study of the same children over a period of 12 years. Gender differences from 5 to 8 years have been reported previously. 16 The aim of this analysis was to investigate gender differences in IR between 9 and 16 years. We hypothesized that the adverse metabolic profile of girls (compared with boys) would persist from childhood through adolescence.
| PATIENTS AND METHODS

| Design, setting, and participants
EarlyBird is a non-intervention longitudinal cohort study of 347 chil- Unit website (www.dtu.ox.ac.uk). 23 A venous blood sample was taken at 9 AM after an overnight fast. Serum insulin was measured by Immulite analyser (Diagnostic Products Corporation, Los Angeles, California), cross-reactivity with proinsulin <1%, inter-assay coefficient of variation (CV) 9%, detection limit of the assay 2.0 mU/L (14 pmol/L).
Glucose was measured using Cobas Integra 700 analyser (Roche Diagnostics GmbH, Mannheim, Germany; inter-assay CV 2%).
HOMA-IR has been validated against the euglycemic clamp (r = 0.91) in healthy youths. 24 
| Secondary outcome measures
High-density lipoprotein-cholesterol (HDL-C) and triglycerides were measured using Cobas Integra 700 analyser (Roche Diagnostics) and inter-assay CV 2%. by the UK Government to be the lower limit of moderate activity. 29 Children's MVPA varied little from 9 to 16 years, 30 and in order to characterize the overall long-term physical activity level of each child, their MVPA was averaged across all 8 time points. In doing so, the children were ranked according to their activity levels throughout the whole period with 95% reliability, compared with 70% reliability when using 1 annual measure of physical activity. 30 
| Predictor variables
| Statistical analysis
The distributions of HOMA-IR, triglycerides, % fat, and MVPA, were skewed in both genders and were log-transformed for analysis and back-transformed for presentation. Cross-sectional analyses were performed using IBM SPSS version 22 (IBM Corp., Armonk, New York). The gender difference between mean values was expressed as a percentage. Differences between individuals were assessed by independent t tests. Univariate regression explored the association between the outcome variable and predictor variables.
Longitudinal data were analyzed using linear mixed-effects modelling taking into account all available data at each time-point (R software 31 using lmer function in lme4 32 ). The effect of covariates on the gender difference in IR over time was examined. Random intercepts were included as well as age (categorized to allow for nonlinear change in IR over time), gender, % fat, APHV, and MVPA as fixed effects. Two-way interactions between the covariates, age, and gender were examined and retained in the model if significant at the 5% level or of particular interest. Interpretation of the model coefficients was facilitated by plotting.
| RESULTS
A total of 292 children (147 boys) had measures of IR at 9 years (84% of the cohort), and these subjects were used for this analysis. Descriptive characteristics are shown in Table 1 . The girls attained peak height velocity 1.64 years before boys. Girls had significantly higher % body fat at each age, larger waist circumferences from 10 years onwards, and a significantly higher BMIsds at 14 years (P = .003).
IR rose and fell through puberty in both genders, with boys reaching peak IR at 14 years, and girls at 12 years. IR was significantly higher in girls than boys at each age up to 15 years, with the biggest gender difference at 12 years. Girls had 13% to 18% higher triglycerides than boys from 9 to 14 years (P < .032), but the difference was no longer significant at 15 and 16 years. Boys had 3% to 7% higher HDL-C than girls from 9 to 12 years (P < .02), whereas by 15 years girls had 7% higher HDL-C (P = .02), and by 16 years girls were 9% higher (P < .001).
| Univariate regression
Predictor variables were added separately at each age to assess their contribution to IR (Table S1 , Supporting Information). The variable having the greatest effect on the gender difference in IR was % fat.
After adjusting for fat there was no significant gender difference in IR at ages 9 to 11, 14, and 15 years. At 12 and 13 years, girls were still more insulin resistant than boys after accounting for fat (P < .001
and .018 respectively), and at 16 years, girls were 40% less insulin resistant than boys (P < .001). Waist circumference, BMI, APHV, and MVPA each had more modest effects in attenuating the gender difference in IR. When these variables were included in the models, girls remained more insulin resistant than boys throughout.
Adjusting for % fat, APHV and MVPA increased the gender difference in HDL-C levels at 16 years, with % fat having the greatest effect (girls 25% higher than boys; P < .001). The only predictor variable which influenced the gender difference in triglycerides at 16 years was % fat, adjusting for which led to girls having 20% lower levels than boys (P < .001).
Fasting glucose levels were significantly higher in the boys than girls at 10 years and 13 to 16 years. The gender difference in glucose was explained by APHV at 14 and 15 years, but adjusting for adiposity and MVPA made little difference.
| Longitudinal modelling
The measure of adiposity explaining the greatest proportion of the gender difference in IR was total % fat, therefore this was included as a covariate in the longitudinal models along with objective measures of APHV and MVPA, as these are also known to influence IR. Figure 1A shows the unadjusted IR (model estimates are given in Table S2 ). Figure 1B shows IR adjusted for APHV alone, Figure 1C shows IR adjusted for APHV and MVPA, and After adjustment ( Figure 2B ), HDL-C became significantly higher in the girls from 12 years onwards such that by 16 years, HDL-C was approximately 22% higher in girls than boys (Table S3 ). Triglycerides increased in both genders, girls having 13% to 18% higher levels than boys from 9 to 14 years (raw data, Figure 2C ). However, after adjustment for % fat, APHV and MVPA, there was no gender difference in triglycerides until 16 years when the girls had approximately 20% lower levels than boys ( Figure 2D ; Table S4 ).
| DISCUSSION
The principal finding of this study was that IR is significantly higher in adolescent girls than boys, and this gender difference narrows and reverses by age 16 years, at which age boys become more insulin resistant than girls. After adjusting for factors known to influence IR, the gender difference in IR between 9 and 15 years was largely attributable to differences in adiposity. Furthermore, these findings were largely mirrored by changes in levels of triglycerides and HDL-C levels, which support the likely biological significance of the temporal changes in IR.
Fasting glucose levels were slightly higher in boys, and this gender difference was attenuated to some extent by pubertal stage, and not by adiposity or activity. (Continues) participants has allowed us to identify more precisely the age at Abbreviations: B, boys; DEXA, dual energy x-ray absorptiometry; G, girls; HDL-C, high-density lipoprotein-cholesterol; IQR, interquartile range; MVPA, moderate-and-vigorous intensity physical activity; SDS, standard deviation score. The HDL-C data are in line with the normative data collected by the Caliper study, 34 showing slightly higher levels in girls from 13 to 19 years, and no gender difference in triglyceride levels.
The gender differences observed in metabolic variables could be explained by changes in fat distribution, with boys accumulating more central adiposity, known to be associated with increased IR and diabetes risk, and girls accumulating more subcutaneous and/or gluteal adiposity. However, waist circumference-SDS increased significantly in the girls from 9 to 16 years but did not change in the boys, suggesting that the girls were accumulating excess abdominal fat, while boys were growing at the expected rate. Despite this potential masking effect of excess weight gain in girls, we report a cross-over in the gender difference in IR and lipids. Therefore, we are unable to explain the observed gender differences in IR and lipids by changes in body composition. Further studies using direct measures of visceral adiposity could clarify this issue.
Another possibility is that peripubertal changes in IR are influenced by changing sex-steroid concentrations. The postpubertal decline in IR in girls might be related to rising oestrogen concentrations; oestrogen has several insulin-sensitizing effects. 35 Alternatively, rising androgen levels in both genders could affect IR. Testosterone has been shown to decrease insulin sensitivity in both men and women. 36 However, levels of sex hormone-binding globulin, which are strongly influenced by adiposity and IR in childhood, 37 Physical activity is a potential factor that could influence metabolic health in adolescence, and may be highly relevant to diabetes and cardiovascular disease prevention strategies in young people.
Physical activity declines during adolescence, 40 and while there was considerable inter-individual variation in activity levels at each time point, intra-individual activity remained remarkably stable. Ranking the participants according to their 8-year activity levels allowed maximum precision, yet the overall contribution of activity to the gender difference in IR and lipids was modest.
We have previously shown that physical activity attenuates the mid-adolescent peak in IR and that this effect disappears by 16 years, independent of adiposity and pubertal stage. 30 In our final model, however, physical activity explained only a small proportion of the gender difference in IR. Whether or not a modest increase in physical activity in high risk teenagers reduces their risk of T2D remains uncertain.
These findings may have practical relevance for early interventions designed to prevent or delay the onset of T2D in young people.
It can be suggested that the excess risk of T2D in girls may be explained by their greater IR, although it is unclear how this is associated with beta cell failure. Weight gain between 9 and 16 years, a key influence on IR, is a potential target for intervention. Whether or not IR and other characteristics at puberty can predict subsequent hyperglycaemia will require longer term follow-up of the cohort.
This study has strengths and limitations. EarlyBird is a wellestablished longitudinal cohort study with high retention and criterion measures of IR, fatness, and activity. The narrow age range and multiple repeated measures allow for within-and between-subject comparisons. Longitudinal modelling uses all the available data while accommodating missing data points, and our methods allowed for retention of subjects in analyses despite some missing data points.
Inevitably, some data is missing over an 8-year study, particularly measures of MVPA at later ages, and reliability was maximized by calculating a mean value over 8 years. Although pubertal stage was not directly assessed, APHV is a well-established objective surrogate for direct assessment of pubertal stage. It was unfeasible to take more than 1 fasting measure from the children each year, thus insulin was Age (years) Triglycerides (mg/dL) FIGURE 2 Lipid levels (mean, 95% age at peak height velocity [CI]) in children from 9 to 16 years according to gender. A, Highdensity lipoprotein-cholesterol (HDL-C) unadjusted; B, adjusted for % fat, age at peak height velocity (APHV) and moderateand-vigorous intensity physical activity (MVPA); C, triglycerides unadjusted; D, adjusted for % fat, APHV, and MVPA measured from a single sample rather than the mean of 3. HOMA is a surrogate measure of IR, but, correlating strongly with results from clamp studies, it is the most appropriate measure to use in young children. Accelerometry is a robust measure of physical activity, although limitations include the potential to miss upper body movement and the fact that they must be removed for water-based activities. Activity diaries reduced some of these limitations. The EarlyBird cohort is mainly Caucasian, and results may not be generalizable to populations with different ethnic composition. The current analysis terminates at 16 years when the metabolic effects of puberty may persist, especially in boys. Follow-up to adulthood will confirm whether IR remains higher in postpubertal males compared with females, before and after adjustment for adiposity, and whether IR is associated with increased long-term risk for the development of T2D.
We conclude that the higher IR of prepubertal and early pubertal girls appears to be largely explained by their greater fat mass, with more modest effects of physical activity and the timing of puberty.
Around the age of 16 years a "cross-over" point is reached when, despite their lower fat mass and higher activity levels, boys become more insulin resistant than girls, and have higher triglycerides and lower HDL-C levels. The changing risk factors for boys and girls will inform diabetes prevention strategies in children.
